Insufficient scRNA-seq data for expression of TICRR at single-cell level.
Insufficient scRNA-seq data for expression of TICRR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 692.64 | 1445 / 1445 | 99% | 12.23 | 182 / 183 |
uterus | 99% | 262.84 | 169 / 170 | 98% | 8.56 | 451 / 459 |
intestine | 100% | 240.71 | 962 / 966 | 97% | 5.79 | 512 / 527 |
ovary | 100% | 287.37 | 180 / 180 | 95% | 4.74 | 408 / 430 |
bladder | 100% | 227.57 | 21 / 21 | 94% | 4.86 | 474 / 504 |
skin | 98% | 451.84 | 1775 / 1809 | 95% | 4.53 | 447 / 472 |
breast | 99% | 217.82 | 456 / 459 | 87% | 4.07 | 971 / 1118 |
lung | 92% | 132.54 | 531 / 578 | 83% | 5.13 | 958 / 1155 |
stomach | 73% | 149.86 | 262 / 359 | 98% | 6.23 | 279 / 286 |
brain | 47% | 39.87 | 1252 / 2642 | 76% | 2.27 | 539 / 705 |
thymus | 100% | 185.45 | 650 / 653 | 18% | 0.83 | 107 / 605 |
prostate | 100% | 255.11 | 245 / 245 | 16% | 0.32 | 79 / 502 |
adrenal gland | 91% | 111.10 | 235 / 258 | 13% | 0.39 | 29 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 4.99 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.71 | 1 / 1 |
spleen | 100% | 254.85 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 226.69 | 1191 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 94% | 181.63 | 1258 / 1335 | 0% | 0 | 0 / 0 |
kidney | 72% | 76.71 | 64 / 89 | 13% | 0.29 | 118 / 901 |
pancreas | 11% | 9.40 | 35 / 328 | 67% | 1.64 | 119 / 178 |
heart | 59% | 59.87 | 509 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 52% | 594.01 | 479 / 929 | 0% | 0 | 0 / 0 |
liver | 15% | 17.71 | 35 / 226 | 35% | 0.79 | 143 / 406 |
muscle | 13% | 10.71 | 101 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 0.14 | 8 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007095 | Biological process | mitotic G2 DNA damage checkpoint signaling |
GO_0033314 | Biological process | mitotic DNA replication checkpoint signaling |
GO_0006281 | Biological process | DNA repair |
GO_0006260 | Biological process | DNA replication |
GO_0030174 | Biological process | regulation of DNA-templated DNA replication initiation |
GO_0010212 | Biological process | response to ionizing radiation |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | TICRR |
Protein name | TOPBP1 interacting checkpoint and replication regulator Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein) |
Synonyms | C15orf42 |
Description | FUNCTION: Regulator of DNA replication and S/M and G2/M checkpoints. Regulates the triggering of DNA replication initiation via its interaction with TOPBP1 by participating in CDK2-mediated loading of CDC45L onto replication origins. Required for the transition from pre-replication complex (pre-RC) to pre-initiation complex (pre-IC). Required to prevent mitotic entry after treatment with ionizing radiation. . |
Accessions | H0YN97 Q7Z2Z1 ENST00000560985.5 [Q7Z2Z1-2] ENST00000561095.1 ENST00000268138.12 [Q7Z2Z1-1] |